BRIEF-Vectura receives Norwegian approval for Airflusal Forspiro

Mon Feb 10, 2014 11:41am EST

Related Topics

Feb 10 (Reuters) - Vectura Group PLC : * Norwegian regulatory authority confirm approval of airflusal forspiro * Treatment is new inhaler for patients with asthma and chronic obstructive

pulmonary disease (copd). * Source text

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.